Targeted alpha therapy using [Bi-213]Substance P overcomes chemo- and radioresistance in glioblastoma and glioblastoma stem cells

被引：0
|
作者：
Friesen, C. [1 ]
Hormann, I. [1 ]
Roscher, M. [1 ]
Morgenstern, A. [2 ]
Bruchertseifer, F. [2 ]
Maecke, H. [3 ]
Fulda, S. [4 ]
Apostolidis, C. [2 ]
Debatin, K. -M. [4 ]
Miltner, E. [1 ]
机构：
[1] Univ Ulm, Inst Rechts Med, Ulm, Germany
[2] Europa Kommiss, Inst Transurane, Karlsruhe, Germany
[3] Univ Freiburg, Freiburg, Germany
[4] Univ Ulm, Klin Kinder & Jugendmed, Ulm, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
  • [41] CD 44 Glioblastoma stem cells and resistance to alpha ionizing radiation: new insights into therapy
    Rosiak, E.
    Matyskiel, R.
    Koziara, H.
    Krolicki, B.
    Krolicki, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S174 - S175
  • [42] In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen
    Li Y.
    Tian Z.
    Rizvi S.M.A.
    Bander N.H.
    Allen B.J.
    Prostate Cancer and Prostatic Diseases, 2002, 5 (1) : 36 - 46
  • [43] In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen
    Li, Y
    Tian, Z
    Rizvi, SMA
    Bander, NH
    Allen, BJ
    PROSTATE CANCER AND PROSTATIC DISEASES, 2002, 5 (01) : 36 - 46
  • [44] RADIOIMMUNOTHERAPY USING ANTI-CD33 ANTIBODIES RADIOLABELED WITH THORIUM-226 OR BISMUTH-213 OVERCOME CHEMO- AND RADIORESISTANCE IN MYELOID LEUKEMIA CELLS
    Friesen, C.
    Roscher, M.
    Morgenstern, A.
    Bruchertseifer, F.
    Abbas, K.
    Apostolidis, C.
    Miltner, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 329 - 329
  • [45] Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
    Kaluzova, Milota
    Bouras, Alexandros
    Machaidze, Revaz
    Hadjipanayis, Costas G.
    ONCOTARGET, 2015, 6 (11) : 8788 - 8806
  • [46] Mutagenesis induced by targeted alpha therapy using 213Bi-cDTPA-9.2.27 in lacZ transgenic mice
    Allen, Barry J.
    So, Trina
    Rizvi, Syed M. Abbas
    Song, Emma Y.
    Fernandez, Harvey R.
    Lutz-Mann, Louise
    CANCER BIOLOGY & THERAPY, 2009, 8 (09) : 777 - 781
  • [47] Glioblastoma xenografts obtained from patient derived cancer stem cells preserve the heterogeneous response to targeted therapy
    decarvalho, Ana C.
    Hasselbach, Laura
    Nelson, Kevin
    Mikkelsen, Tom
    CANCER RESEARCH, 2011, 71
  • [48] Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells
    Han, Jang Mi
    Kim, Yu Jin
    Jung, Hye Jin
    CANCERS, 2022, 14 (05)
  • [49] Nuclear Magnetic Resonance Spectroscopy to Identify Metabolite Biomarkers of Nonresponsiveness to Targeted Therapy in Glioblastoma Tumor Stem Cells
    Hvinden, Ingvild Comfort
    Berg, Henriette Engen
    Sachse, Daniel
    Skaga, Erlend
    Skottvoll, Froydis Sved
    Lundanes, Elsa
    Sandberg, Cecilie J.
    Vik-Mo, Einar O.
    Rise, Frode
    Wilson, Steven Ray
    JOURNAL OF PROTEOME RESEARCH, 2019, 18 (05) : 2012 - 2020
  • [50] ESTABLISHMENT OF GENETICALLY DISTINCT BRAIN TUMOR STEM CELLS FROM GLIOBLASTOMA BEFORE AND AFTER MOLECULAR TARGETED THERAPY
    Tanaka, Shota
    Luk, Samantha
    Chang, Clarice
    Iafrate, John
    Cahill, Daniel
    Martuza, Robert
    Rabkin, Samuel
    Chi, Andrew
    Wakimoto, Hiroaki
    NEURO-ONCOLOGY, 2013, 15 : 216 - 216
12345